|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-4-1
|
|
pubmed:abstractText |
Evidence confirms the positive effects of lipid-lowering agents on the risk of cardiovascular disease. Local guidelines in France (AFSSAPS) have defined therapeutic objectives for LDL-cholesterol. These objectives vary with the number of cardiovascular risk factors in addition to dyslipidaemia. We determined the proportions of patients at therapeutic objective in different classes of cardiovascular risk to test the hypothesis that compliance with guidelines varies across the levels of risk. Comparison with international guidelines (ANDEM) was also performed.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-10441607,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-10695686,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-10860012,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-11259143,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-11779522,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-12114036,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-12663406,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-12964575,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-2535647,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-4337382,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-7566020,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-8801446,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-9388100,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15801941-9841303
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0306-5251
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
456-63
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15801941-Adult,
pubmed-meshheading:15801941-Aged,
pubmed-meshheading:15801941-Chi-Square Distribution,
pubmed-meshheading:15801941-Coronary Disease,
pubmed-meshheading:15801941-Family Practice,
pubmed-meshheading:15801941-Female,
pubmed-meshheading:15801941-France,
pubmed-meshheading:15801941-Guideline Adherence,
pubmed-meshheading:15801941-Humans,
pubmed-meshheading:15801941-Hyperlipidemias,
pubmed-meshheading:15801941-Hypolipidemic Agents,
pubmed-meshheading:15801941-Male,
pubmed-meshheading:15801941-Middle Aged,
pubmed-meshheading:15801941-Patient Compliance,
pubmed-meshheading:15801941-Practice Guidelines as Topic,
pubmed-meshheading:15801941-Primary Prevention,
pubmed-meshheading:15801941-Risk Factors,
pubmed-meshheading:15801941-Treatment Failure
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Ineffectiveness of lipid-lowering therapy in primary care.
|
|
pubmed:affiliation |
Pharmacoepidemiology, EA3091, CHU-Lyon, France. eric-vanganse@chu-lyon.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
